Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | 0.0028 | 0.9 |
mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | 0.0024 | 0.9 |
mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | 0.0036 | 0.9 |
mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | 0.0037 | 0.9 |
mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | 0.0023 | 0.9 |
mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | 0.0049 | 0.9 |
mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | -0.0024 | 0.9 |
mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | -0.0023 | 1 |
mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | -0.0025 | 1 |
mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |